Oxidative stress markers are associated to vascular recurrence in non-cardioembolic stroke patients non-treated with statins

BMC Neurol. 2012 Aug 3:12:65. doi: 10.1186/1471-2377-12-65.

Abstract

Background: Since atherogenesis is related to oxidative stress, our objective was to study the association of oxidative stress markers with the vascular recurrence in non-cardioembolic stroke.

Methods: Atherosclerotic and oxidative stress markers were evaluated on admission, in 477 patients suffering from a first non-cardioembolic stroke. Patients were followed at 6 and 12 months after inclusion, recording cardiovascular events. As markers of endothelial oxidative stress we used oxidized LDL, Cu/Zn superoxide dismutase and 8-OH deoxiguanosine. 136 patients were being treated with statins at the moment of serum samples acquisition.

Results: Patients who suffered vascular recurrence or vascular-origin death had higher levels of 8-OHDG (40.06 ± 24.70 vs 33.11 ± 15.18;p=0.003). We also found associations between vascular recurrence or vascular origin death and Cu/ZnSOD (OR,1.02; 95%CI,1.00-1.03;p=0.0001) and 8-OHDG (OR,1.12;95%CI,1.08-1.16;p<0.0001) in a subgroup of 333 patients that were not in treatment with statins on admission. We also found associations between 8-OHDG and intima media thickness (IMT) (OR,1.13;95%CI,1.09-1.16;p<0.0001), presence of ipsilatieral stenosis ≥ 50% (OR,1.03;95%CI 1.00-1.05;p=0.007) and other atherosclerotic plaque characteristics.

Conclusions: Specific oxidative stress markers were found to be markers of atherosclerosis plaque types and vascular recurrence in non-statins treated patients at admission.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Cerebrovascular Disorders / blood*
  • Cerebrovascular Disorders / drug therapy
  • Cerebrovascular Disorders / epidemiology*
  • Comorbidity
  • Embolism / blood
  • Embolism / drug therapy
  • Embolism / epidemiology
  • Female
  • Heart Diseases / blood
  • Heart Diseases / drug therapy
  • Heart Diseases / epidemiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Male
  • Middle Aged
  • Oxidative Stress*
  • Prevalence
  • Reactive Oxygen Species / blood*
  • Recurrence
  • Risk Factors
  • Spain / epidemiology
  • Stroke / blood*
  • Stroke / drug therapy
  • Stroke / epidemiology*

Substances

  • Biomarkers
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Reactive Oxygen Species